TheracosBio LLC
Classification
Private
About
About
TheracosBio is a pharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines aimed at treating common diseases. The company emphasizes appropriate pricing to ensure that its groundbreaking therapeutic technologies are accessible to a broader audience. Product/Service Line Breakdown: 1. Diabetes Treatment: Development and commercialization of therapies targeting diabetes, focusing on innovative compounds with significant therapeutic benefits. 2. Cardiovascular Disease: Research and development of treatments for various cardiovascular conditions to address the unmet needs in this critical area of healthcare. 3. Other Chronic Diseases: Exploration and creation of medicinal solutions for other prevalent chronic diseases, leveraging advanced pharmaceutical technologies and research.
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private